DocMorris AG | WebDisclosure

Basculer en Français

11127	Companies
245082	Keywords
173186	Articles
132209	Press releases

Home
Companies
DocMorris AG

PRESS RELEASE

published on 05/08/2025 at 06:58, 1 year 4 months ago

DocMorris announces final details on the agenda of today's Annual General Meeting and the planned capital increase
DocMorris AG announces final details on the agenda of today's Annual General Meeting and the planned fully underwritten capital increase, targeting growth in Rx business and repayment of convertible bond

Annual General Meeting Capital Increase Convertible Bond DocMorris AG Rx Business
BRIEF

published on 04/10/2025 at 07:03, 1 year 5 months ago

DocMorris Reports Significant Growth and Capital Increase

EBITDA Capital Increase DocMorris TeleClinic Rx Growth
BRIEF

published on 04/10/2025 at 07:03, 1 year 5 months ago

DocMorris annonce une croissance significative et une augmentation de capital

EBITDA Augmentation De Capital Doc Morris TéléClinique Croissance Sur Ordonnance
PRESS RELEASE

published on 04/10/2025 at 06:58, 1 year 5 months ago

DocMorris accelerates Rx growth to 52 per cent and secures CHF 200 million capital increase through firm underwriting
DocMorris accelerates Rx growth to 52% and secures CHF 200 million capital increase through underwriting. All business areas grow by 13.4% in the first quarter

Capital Increase CHF 200 Million DocMorris Underwriting Rx Growth
BRIEF

published on 03/13/2025 at 07:03, 1 year 6 months ago

DocMorris Meets 2024 Goals, Projects Significant Growth for 2025

Sustainability Capital Increase 2024 Targets DocMorris Rx Growth
BRIEF

published on 03/13/2025 at 07:03, 1 year 6 months ago

DocMorris atteint ses objectifs pour 2024 et prévoit une croissance significative pour 2025

Augmentation De Capital Durabilité Objectifs 2024 Doc Morris Croissance Sur Ordonnance
PRESS RELEASE

published on 03/13/2025 at 06:58, 1 year 6 months ago

DocMorris achieves 2024 targets, expects Rx growth of around 50 per cent in the first quarter of 2025 and plans capital increase
DocMorris achieves 2024 targets, expects Rx growth of around 50% in Q1 2025 and plans CHF 200 million capital increase. Revenue targets met, positive results in Germany & Europe

Revenue Growth Capital Increase 2024 Targets DocMorris Rx Growth
BRIEF

published on 02/27/2025 at 12:41, 1 year 7 months ago

ECJ Ruling Impacts DocMorris Advertising Strategy

DocMorris AG ECJ Ruling Prescription Medicine Discounts German Court Case Advertising Regulations
BRIEF

published on 02/27/2025 at 12:41, 1 year 7 months ago

La décision de la CJUE impacte la stratégie publicitaire de DocMorris

DocMorris AG Arrêt De La CJCE Rabais Sur Les Médicaments Sur Ordonnance Affaire Judiciaire Allemande Réglementation Sur La Publicité
PRESS RELEASE

published on 02/27/2025 at 12:36, 1 year 7 months ago

DocMorris AG: ECJ Ruling on advertising for prescription medicines
DocMorris AG: ECJ ruling permits Rx discount promotions with vouchers for beauty and personal care products. Company to focus on digitalization and e-prescriptions growth in Germany

Digitalization DocMorris AG ECJ Ruling Prescription Medicines Discount Promotions

Accesswire

Published on 10/05/2026 at 22:30, 5 hours 9 minutes ago

EV Nickel Announces Formation of Wholly Owned Subsidiary to Advance Nickel Bioleaching Technology and Canadian Nickel Supply Chain
Published on 10/05/2026 at 14:45, 12 hours 54 minutes ago

NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 13 hours 9 minutes ago

Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 13 hours 9 minutes ago

Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 13 hours 39 minutes ago

Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth

View all ACCESSWIRE

EQS Group

Published on 10/06/2026 at 03:00, 39 minutes ago

Qupital Unveils World’s First AI-Driven On-Chain E-Commerce Lending Protocol, Accelerating Web3 Global Trade Finance
Published on 10/05/2026 at 22:25, 5 hours 14 minutes ago

LumApps Named a Leader in 2026 Gartner® Magic Quadrant™ for Intranet Packaged Solutions
Published on 10/05/2026 at 22:05, 5 hours 34 minutes ago

AMPERA SUBMITS COMPREHENSIVE ENGAGEMENT PLAN TO THE U.S. NUCLEAR REGULATORY COMMISSION
Published on 10/05/2026 at 21:10, 6 hours 29 minutes ago

Shelly Group Board of Directors considers EUR 70.00 offer price fair and supports Schneider Electric’s voluntary public tender offer
Published on 10/05/2026 at 21:05, 6 hours 33 minutes ago

EQS-Adhoc: Shelly Group SE: Board of Directors with positive opinion on the registered voluntary public tender offer by Schneider Electric SE

Les Echos

Published on 10/05/2026 at 22:12, 5 hours 27 minutes ago

AXA - Elimination of the dilutive impact of Shareplan 2026
Published on 10/05/2026 at 22:12, 5 hours 27 minutes ago

AXA - Elimination de l'effet dilutif de l'opération Shareplan 2026
Published on 10/05/2026 at 18:13, 9 hours 26 minutes ago

Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 9 hours 26 minutes ago

Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 9 hours 39 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026

View all LES ECHOS COMFI WIRE